| Emulating randomized clinical trials with nonrandomized real-world evidence studies: first results from the RCT DUPLICATE initiative JM Franklin, E Patorno, RJ Desai, RJ Glynn, D Martin, K Quinto, A Pawar, ... Circulation 143 (10), 1002-1013, 2021 | 245 | 2021 |
| Empagliflozin and the risk of heart failure hospitalization in routine clinical care: a first analysis from the EMPRISE study E Patorno, A Pawar, JM Franklin, M Najafzadeh, A Déruaz-Luyet, ... Circulation 139 (25), 2822-2830, 2019 | 205 | 2019 |
| Risk of serious infections in tocilizumab versus other biologic drugs in patients with rheumatoid arthritis: a multidatabase cohort study A Pawar, RJ Desai, DH Solomon, AJS Ortiz, S Gale, M Bao, K Sarsour, ... Annals of the rheumatic diseases 78 (4), 456-464, 2019 | 194 | 2019 |
| Validation of a claims-based frailty index against physical performance and adverse health outcomes in the health and retirement study DH Kim, RJ Glynn, J Avorn, LA Lipsitz, K Rockwood, A Pawar, ... The Journals of Gerontology: Series A 74 (8), 1271-1276, 2019 | 177 | 2019 |
| Emulation of randomized clinical trials with nonrandomized database analyses: results of 32 clinical trials SV Wang, S Schneeweiss, JM Franklin, RJ Desai, W Feldman, EM Garry, ... Jama 329 (16), 1376-1385, 2023 | 135 | 2023 |
| Comparative risk of venous thromboembolism in rheumatoid arthritis patients receiving tofacitinib versus those receiving tumor necrosis factor inhibitors: an observational … RJ Desai, A Pawar, ME Weinblatt, SC Kim Arthritis & Rheumatology 71 (6), 892-900, 2019 | 115* | 2019 |
| Measuring frailty in administrative claims data: comparative performance of four claims-based frailty measures in the US Medicare data DH Kim, E Patorno, A Pawar, H Lee, S Schneeweiss, RJ Glynn The Journals of Gerontology: Series A 75 (6), 1120-1125, 2020 | 113 | 2020 |
| Nonrandomized real‐world evidence to support regulatory decision making: process for a randomized trial replication project JM Franklin, A Pawar, D Martin, RJ Glynn, M Levenson, R Temple, ... Clinical Pharmacology & Therapeutics 107 (4), 817-826, 2020 | 109 | 2020 |
| Comparative effectiveness and safety of sodium–glucose cotransporter 2 inhibitors versus glucagon-like peptide 1 receptor agonists in older adults E Patorno, A Pawar, LG Bessette, DH Kim, C Dave, RJ Glynn, MN Munshi, ... Diabetes care 44 (3), 826-835, 2021 | 87 | 2021 |
| Frailty and clinical outcomes of direct oral anticoagulants versus warfarin in older adults with atrial fibrillation: a cohort study DH Kim, A Pawar, JJ Gagne, LG Bessette, H Lee, RJ Glynn, ... Annals of internal medicine 174 (9), 1214-1223, 2021 | 84 | 2021 |
| Sodium–glucose cotransporter-2 inhibitors versus glucagon-like peptide-1 receptor agonists and the risk for cardiovascular outcomes in routine care patients with diabetes … E Patorno, PT Htoo, RJ Glynn, S Schneeweiss, DJ Wexler, A Pawar, ... Annals of internal medicine 174 (11), 1528-1541, 2021 | 67 | 2021 |
| Predictors of drug shortages and association with generic drug prices: a retrospective cohort study CV Dave, A Pawar, ER Fox, G Brill, AS Kesselheim Value in health 21 (11), 1286-1290, 2018 | 67 | 2018 |
| Maternal and fetal outcomes following exposure to duloxetine in pregnancy: cohort study KF Huybrechts, BT Bateman, A Pawar, LG Bessette, H Mogun, R Levin, ... bmj 368, 2020 | 56 | 2020 |
| Reproducibility of real-world evidence studies using clinical practice data to inform regulatory and coverage decisions SV Wang, SK Sreedhara, S Schneeweiss Nature communications 13 (1), 5126, 2022 | 55 | 2022 |
| Risk of admission to hospital for serious infection after initiating tofacitinib versus biologic DMARDs in patients with rheumatoid arthritis: a multidatabase cohort study A Pawar, RJ Desai, N Gautam, SC Kim The Lancet Rheumatology 2 (2), e84-e98, 2020 | 55 | 2020 |
| Risk of malignancy associated with use of tocilizumab versus other biologics in patients with rheumatoid arthritis: a multi-database cohort study SC Kim, A Pawar, RJ Desai, DH Solomon, S Gale, M Bao, K Sarsour, ... Seminars in arthritis and rheumatism 49 (2), 222-228, 2019 | 55 | 2019 |
| Risk of venous thromboembolism associated with tofacitinib in patients with rheumatoid arthritis: a population-based cohort study RJ Desai, A Pawar, F Khosrow-Khavar, ME Weinblatt, SC Kim Rheumatology 61 (1), 121-130, 2022 | 54 | 2022 |
| Variation in prescription drug prices by retail pharmacy type: a national cross-sectional study J Luo, M Kulldorff, A Sarpatwari, A Pawar, AS Kesselheim Annals of Internal Medicine 171 (9), 605-611, 2019 | 45 | 2019 |
| Evaluation of antiinflammatory and analgesic activities of ethanolic extract of roots Adhatoda vasica Linn. WA Mulla, SD More, SB Jamge, AM Pawar, MS Kazi, MR Varde | 41 | 2010 |
| Updating International Classification of Diseases 9th Revision to 10th Revision of a claims-based frailty index N Gautam, L Bessette, A Pawar, R Levin, DH Kim The Journals of Gerontology: Series A 76 (7), 1316-1317, 2021 | 38 | 2021 |
